nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author Index
|
|
|
2012 |
44 |
S1 |
p. S49-S54 6 p. |
artikel |
2 |
Editorial Board
|
|
|
2012 |
44 |
S1 |
p. i- 1 p. |
artikel |
3 |
F-35 Adipocyte-fatty acid binding protein, NAFLD and cardiovascular risk in the elderly
|
Martino, E. |
|
2012 |
44 |
S1 |
p. S43- 1 p. |
artikel |
4 |
F-40 A novel metabolic action for the multikinase inhibitor sorafenib: targeting tumor cells through mitochondrial damage
|
Tesori, V. |
|
2012 |
44 |
S1 |
p. S44- 1 p. |
artikel |
5 |
F-16 Applicability of international guidelines in the therapeutic algorithm of hepatocellular carcinoma
|
Leoni, S. |
|
2012 |
44 |
S1 |
p. S36- 1 p. |
artikel |
6 |
F-31 Berberine ameliorates necroinflammation in experimental steatohepatitis, but is associated with extrahepatic toxicity
|
Vivoli, E. |
|
2012 |
44 |
S1 |
p. S41- 1 p. |
artikel |
7 |
F-15 Caveolin-1 and mitochondrial ultrastructural alterations in regenerating rat liver
|
Mastrodonato, M. |
|
2012 |
44 |
S1 |
p. S36- 1 p. |
artikel |
8 |
F-47 Clinical and genetic factors of response to antiviral treatment of chronic hepatitis C virus infection
|
Masarone, M. |
|
2012 |
44 |
S1 |
p. S46-S47 2 p. |
artikel |
9 |
F-17 Clinical outcome of liver damage in pregnancy: experience from a prospective cohort study
|
Licata, A. |
|
2012 |
44 |
S1 |
p. S36-S37 2 p. |
artikel |
10 |
F-11 Combination of radiofrequency ablation and transcatheter arterial chemoembolization improves survival in advanced hepatocellular carcinoma complicating liver cirrhosis
|
Ventura, P. |
|
2012 |
44 |
S1 |
p. S35- 1 p. |
artikel |
11 |
F-7 Common criterion vs AKIN criteria in the definition of acute kidney injury in hospitalized patients with cirrhosis and ascites
|
Rosi, S. |
|
2012 |
44 |
S1 |
p. S33-S34 2 p. |
artikel |
12 |
F-32 Dietary supplementation with olive oil with or without n-3 PUFA differentially affects inflammation and progression of experimental nonalcoholic steatohepatitis
|
Provenzano, A. |
|
2012 |
44 |
S1 |
p. S42- 1 p. |
artikel |
13 |
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy
|
Caviglia, G.P. |
|
2012 |
44 |
S1 |
p. S42- 1 p. |
artikel |
14 |
F-13 Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C
|
Abbati, G. |
|
2012 |
44 |
S1 |
p. S35- 1 p. |
artikel |
15 |
F-10 Emodin partially reverts diet-induced steatosis and completely reverts inflammation and redox status imbalance in rats
|
Panera, N. |
|
2012 |
44 |
S1 |
p. S34-S35 2 p. |
artikel |
16 |
F-27 Endocannabinoids in advanced cirrhosis: have we picked the right one?
|
Maggioli, C. |
|
2012 |
44 |
S1 |
p. S40- 1 p. |
artikel |
17 |
F-12 Epigenetic modulation of CD40 ligand leads to hyper IgM in patients with primary biliary cirrhosis
|
Lleo, A. |
|
2012 |
44 |
S1 |
p. S35- 1 p. |
artikel |
18 |
F-18 Etiological and clinical characteristics of patients with liver cirrhosis at the onset of first hepatic decompensation: final results of a prospective multicentre AISF collaborative study (EPASCO)
|
Stroffolini, T. |
|
2012 |
44 |
S1 |
p. S37- 1 p. |
artikel |
19 |
F-36 Ex situ liver surgery for the treatment of unresectable tumours: Padova early experience
|
Gringeri, E. |
|
2012 |
44 |
S1 |
p. S43- 1 p. |
artikel |
20 |
F-28 Gender and life-style influences on serum gamma-glutamyltransferase levels: time to change the normal range in the general population
|
Zaccherini, G. |
|
2012 |
44 |
S1 |
p. S40- 1 p. |
artikel |
21 |
F-42 Gender-specific determinants of response in HCV genotype 1 to current SOC with peg IFN and ribavirin in a practice cohort
|
Di Marco, V. |
|
2012 |
44 |
S1 |
p. S45- 1 p. |
artikel |
22 |
F-48 Genetic predictors of response in the treatment of chronic hepatitis C virus infection: interference between SOCS3 and IL28
|
Russo, R. |
|
2012 |
44 |
S1 |
p. S47- 1 p. |
artikel |
23 |
F-46 Graft survival is worse in HCV positive females transplanted with male donor grafts
|
Belli, L. |
|
2012 |
44 |
S1 |
p. S46- 1 p. |
artikel |
24 |
F-43 Hepatitis C in IDUs: preliminary results of an observational, multi-centre study on behalf of FederSerD
|
Chiesa, A. |
|
2012 |
44 |
S1 |
p. S45- 1 p. |
artikel |
25 |
F-6 High NT-pro-BNP levels are associated with cardiac morpho-functional changes in patients with advanced liver cirrhosis
|
Licata, A. |
|
2012 |
44 |
S1 |
p. S33- 1 p. |
artikel |
26 |
F-1 IL28B gene variants and metabolic profile in patients with genotype 1 chronic hepatitis C
|
Rosso, C. |
|
2012 |
44 |
S1 |
p. S32- 1 p. |
artikel |
27 |
F-8 Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin
|
Ibrahim, K.J. |
|
2012 |
44 |
S1 |
p. S34- 1 p. |
artikel |
28 |
F-50 Increased urinary level of neutrophil gelatinase–associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS
|
Cavallin, M. |
|
2012 |
44 |
S1 |
p. S47-S48 2 p. |
artikel |
29 |
F-26 In-house allele specific PCR method to study the kinetics of resistant variants during nucleos(t)ide analogs treatment in immunocompetent and immunocompromised patients
|
Moriconi, F. |
|
2012 |
44 |
S1 |
p. S40- 1 p. |
artikel |
30 |
F-2 Interaction between vitamin D binding protein polymorphisms and vitamin D levels in the prediction of antiviral response in chronic hepatitis C
|
Bitetto, D. |
|
2012 |
44 |
S1 |
p. S32- 1 p. |
artikel |
31 |
F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience
|
Ponziani, F.R. |
|
2012 |
44 |
S1 |
p. S38-S39 2 p. |
artikel |
32 |
F-14 Lipopolysaccharide-induced tumor necrosis factor-alpha and hepatic stellate cell proliferation and activation
|
Ceccarelli, S. |
|
2012 |
44 |
S1 |
p. S36- 1 p. |
artikel |
33 |
F-39 Management of symptomatic osteoporosis after liver transplantation in a real-world setting
|
Valente, G. |
|
2012 |
44 |
S1 |
p. S44- 1 p. |
artikel |
34 |
F-41 Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy
|
Piluso, A. |
|
2012 |
44 |
S1 |
p. S44-S45 2 p. |
artikel |
35 |
F-3 Notch3 silencing and sorafenib as combinate treatment for human hepatocellular carcinoma
|
Baglioni, M. |
|
2012 |
44 |
S1 |
p. S32- 1 p. |
artikel |
36 |
F-49 Overall survival of patients undergoing liver resection for hepatocellular carcinoma may be predicted by KIR2DL5 and HLA Bw4I80 genotyping
|
Cariani, E. |
|
2012 |
44 |
S1 |
p. S47- 1 p. |
artikel |
37 |
F-44 Prevalence and aetiology of transaminases abnormalities in the general population of a small Italian town: the Bagnacavallo study
|
Dall'Aglio, A. |
|
2012 |
44 |
S1 |
p. S45-S46 2 p. |
artikel |
38 |
F-21 Primary biliary cirrhosis in Lombardia: a lower than expected female-to-male incidence ratio with higher mortality in men
|
Moroni, L. |
|
2012 |
44 |
S1 |
p. S38- 1 p. |
artikel |
39 |
F-5 Prospective validation of 2010 AASLD guideline for the diagnosis of 1-2 cm HCC in cirrhotic patients
|
Manini, M.A. |
|
2012 |
44 |
S1 |
p. S33- 1 p. |
artikel |
40 |
F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT)
|
Gambato, M. |
|
2012 |
44 |
S1 |
p. S39-S40 2 p. |
artikel |
41 |
F-45 Rapid virologic response (RVR), IL28B single nucleotide polymorphism (SNP) rs12980275 and HCV genotype are independent predictors of sustained virologic response (SVR) in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin
|
Puoti, M. |
|
2012 |
44 |
S1 |
p. S46- 1 p. |
artikel |
42 |
F-22 Recipient serum total and LDL cholesterol concentration at transplant predicts graft survival after liver transplantation independently from MELD score
|
Corradini, S. Ginanni |
|
2012 |
44 |
S1 |
p. S38- 1 p. |
artikel |
43 |
F-4 Recipient's vitamin D receptor genetic polymorphisms identify HCV positive liver transplanted patients at lower risk of graft fibrosis progression due to recurrent hepatitis C
|
Bitetto, D. |
|
2012 |
44 |
S1 |
p. S32-S33 2 p. |
artikel |
44 |
F-20 Replicative capacity and response to interferon-alpha treatment of HBV isolates belonging to different genotypes
|
Restuccia, A. |
|
2012 |
44 |
S1 |
p. S37-S38 2 p. |
artikel |
45 |
F-34 Risk factors for central pontine (CPM) and extrapontine myelinolysis (EPM) in liver transplanted recipients: a single center analysis
|
Crivellin, C. |
|
2012 |
44 |
S1 |
p. S42- 1 p. |
artikel |
46 |
F-37 Role of plasmacytoid dendritic cells in liver ischemia/reperfusion injury
|
Castellaneta, A. |
|
2012 |
44 |
S1 |
p. S43- 1 p. |
artikel |
47 |
F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma
|
Ponziani, F.R. |
|
2012 |
44 |
S1 |
p. S39- 1 p. |
artikel |
48 |
F-9 The I148M PNPLA3 polymorphism is associated with the clinical presentation and prognosis of hepatocellular carcinoma
|
Valenti, L. |
|
2012 |
44 |
S1 |
p. S34- 1 p. |
artikel |
49 |
F-30 The receptor CXCR7 contributes to proliferation and migration of hepatic stellate cells
|
Provenzano, A. |
|
2012 |
44 |
S1 |
p. S41- 1 p. |
artikel |
50 |
F-38 The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management
|
Faloppi, L. |
|
2012 |
44 |
S1 |
p. S43-S44 2 p. |
artikel |
51 |
F-19 The silybin-phospholipids complex counteracts fatty degeneration, nitrosative and oxidative stress in two rodent models of liver steatosis
|
Grattagliano, I. |
|
2012 |
44 |
S1 |
p. S37- 1 p. |
artikel |
52 |
F-29 Transarterial chemoembolization (TACE) with doxorubicin-eluting-bead versus conventional TACE in patients listed for liver transplantation: impact on tumor necrosis and post transplant disease-free survival
|
Nicolini, D. |
|
2012 |
44 |
S1 |
p. S41- 1 p. |
artikel |
53 |
F-52 US-guided probe positioning does not improve applicability but reduces variability in liver stiffness (FibroScan) measurement
|
Serviddio, G. |
|
2012 |
44 |
S1 |
p. S48- 1 p. |
artikel |
54 |
F-51 Virological response and HBV-DNA reduction during therapy with peginterferon alpha-2a (PEG-IFNα-2a) in patients affected by HBeAg-negative chronic hepatitis B
|
Chessa, L. |
|
2012 |
44 |
S1 |
p. S48- 1 p. |
artikel |
55 |
OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants
|
Avolio, A. |
|
2012 |
44 |
S1 |
p. S10- 1 p. |
artikel |
56 |
OC-18 CD133+ stem cells for the treatment of end stage liver disease
|
Brodosi, L. |
|
2012 |
44 |
S1 |
p. S7- 1 p. |
artikel |
57 |
OC-34 Clinical features and outcome of patients with drug-induced autoimmune hepatitis
|
Licata, A. |
|
2012 |
44 |
S1 |
p. S12- 1 p. |
artikel |
58 |
OC-32 Costs and quality of life in patients with chronic hepatic diseases: the COME study results
|
Fagiuoli, S. |
|
2012 |
44 |
S1 |
p. S11- 1 p. |
artikel |
59 |
OC-27 Hepatic resection versus laparoscopic radiofrequency ablation for “very early” hepatocellular carcinoma
|
Santambrogio, R. |
|
2012 |
44 |
S1 |
p. S9-S10 2 p. |
artikel |
60 |
OC-22 Human gallbladder is a highly available source of stem cells with multiple endodermic mature fates potentiality
|
Cardinale, V. |
|
2012 |
44 |
S1 |
p. S8- 1 p. |
artikel |
61 |
OC-12 Identification of lamivudine resistant HBV strain rt204V/I in acute hepatitis B in Italy
|
Coppola, N. |
|
2012 |
44 |
S1 |
p. S5- 1 p. |
artikel |
62 |
OC-8 IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease
|
Petta, S. |
|
2012 |
44 |
S1 |
p. S3- 1 p. |
artikel |
63 |
OC-10 IL28B genotype, differential expression of intrahepatic interferon-stimulated genes and response to PEG-IFN and ribavirin therapy in an Italian prospective cohort of genotype 1 hepatitis C patients in “real life”
|
Testoni, B. |
|
2012 |
44 |
S1 |
p. S4- 1 p. |
artikel |
64 |
OC-11 IL28B polymorphism in chronic HBV infection: the CC allele does not correlate with the phase of the infection nor with HBsAg clearance in IFN treated patients
|
Cherubini, B. |
|
2012 |
44 |
S1 |
p. S4-S5 2 p. |
artikel |
65 |
OC-9 IL6, IL6-induced miRNAs and HNF1α/HNF4α in the epigenetic control of cccDNA transcription
|
Scisciani, C. |
|
2012 |
44 |
S1 |
p. S4- 1 p. |
artikel |
66 |
OC-24 Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C
|
Bitetto, D. |
|
2012 |
44 |
S1 |
p. S8-S9 2 p. |
artikel |
67 |
OC-30 Interleukin-28B (IL-28B) polymorphism has no impact on the long-term outcome of patients with HCV-related cirrhosis: a 15-years retrospective-prospective cohort study
|
Bruno, S. |
|
2012 |
44 |
S1 |
p. S10-S11 2 p. |
artikel |
68 |
OC-19 Key role of chymase in the hepatic production of angiotensin II and in the development of experimental liver cirrhosis and its complications
|
Sansoè, G. |
|
2012 |
44 |
S1 |
p. S7- 1 p. |
artikel |
69 |
OC-16 Low efficacy of current nucleic acid testing (NAT) assay for the identification of occult HBV infection (OBI) and consequences for safety of blood supply in Italy
|
Spreafico, M. |
|
2012 |
44 |
S1 |
p. S6- 1 p. |
artikel |
70 |
OC-31 Low rates of SVR to peg-interferon plus ribavirin in HCV genotype 1 IL28B rs12979860 CC cirrhotic patients without rapid virological response
|
Degasperi, E. |
|
2012 |
44 |
S1 |
p. S11- 1 p. |
artikel |
71 |
OC-6 Monocyte/macrophage peribiliary recruitment by Pkhd1-defective cholangiocytes induces expression of αvβ6 integrin on biliary cysts via TGFβ1 and TNFα in congenital hepatic fibrosis
|
Locatelli, L. |
|
2012 |
44 |
S1 |
p. S3- 1 p. |
artikel |
72 |
OC-4 Myostatin: a novel modulator of hepatic stellate cell biology
|
Delogu, W. |
|
2012 |
44 |
S1 |
p. S2- 1 p. |
artikel |
73 |
OC-7 NK profiles of non-responder and relapser patients with cHCV infection treated with SOC
|
Oliviero, B. |
|
2012 |
44 |
S1 |
p. S3- 1 p. |
artikel |
74 |
OC-33 Non-invasive diagnosis of non-alcoholic steatohepatitis by combined cytokeratin-18 apoptotic fragment and elastometry
|
Carenzi, S. |
|
2012 |
44 |
S1 |
p. S11-S12 2 p. |
artikel |
75 |
OC-1 PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury: the significance for sclerosing cholangitis
|
Marzioni, M. |
|
2012 |
44 |
S1 |
p. S1- 1 p. |
artikel |
76 |
OC-35 PEG-IFN for chronic hepatitis C in clinical practice: the prospective phase of the AIFA study
|
Rosina, F. |
|
2012 |
44 |
S1 |
p. S12- 1 p. |
artikel |
77 |
OC-36 Peripheral insulin resistance rather than hepatic is a primary defect in non obese, non diabetic, non dyslipidemic NAFLD patients: correlation with liver damage
|
Mezzabotta, L. |
|
2012 |
44 |
S1 |
p. S12-S13 2 p. |
artikel |
78 |
OC-14 Prevalence of occult HBV infection reactivation in a large cohort of Non-Hodgkin Lymphoma (NHL) patients: a retrospective study
|
Masarone, M. |
|
2012 |
44 |
S1 |
p. S5-S6 2 p. |
artikel |
79 |
OC-20 Role of real-time shear wave elastography in assessing fibrosis in chronic hepatitis C
|
Ferraioli, G. |
|
2012 |
44 |
S1 |
p. S7- 1 p. |
artikel |
80 |
OC-2 Selective reduction in S100A4 nuclear expression by low-dose paclitaxel halts invasiveness of human cholangiocarcinoma cells through a Rac1-independent, Rho-A/Cdc42-dependent mechanism
|
Sambado, L. |
|
2012 |
44 |
S1 |
p. S1-S2 2 p. |
artikel |
81 |
OC-5 Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury
|
Arcidiacono, D. |
|
2012 |
44 |
S1 |
p. S2-S3 2 p. |
artikel |
82 |
OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F.
|
Cavallin, M. |
|
2012 |
44 |
S1 |
p. S10- 1 p. |
artikel |
83 |
OC-17 The A736V TMPRSS6 polymorphism is associated with the penetrance of hereditary hemochromatosis and hepatocellular carcinoma in C282Y+/+ patients
|
Valenti, L. |
|
2012 |
44 |
S1 |
p. S6- 1 p. |
artikel |
84 |
OC-21 The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR
|
Prati, G.M. |
|
2012 |
44 |
S1 |
p. S7-S8 2 p. |
artikel |
85 |
OC-26 The emerging impact of HCC-NAFLD in Italy
|
Bellentani, S. |
|
2012 |
44 |
S1 |
p. S9- 1 p. |
artikel |
86 |
OC-25 The genetic background differentially affects hepatic necro-inflammation in response to CCL2 in a murine model of steatohepatitis
|
Galastri, S. |
|
2012 |
44 |
S1 |
p. S9- 1 p. |
artikel |
87 |
OC-13 The role of VEGF and VEGFR polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib
|
Faloppi, L. |
|
2012 |
44 |
S1 |
p. S5- 1 p. |
artikel |
88 |
OC-3 Transplantation of adipose tissue-mesenchymal stem cells in rats with acetaminophen-induced liver failure: effects on oxidative stress and JNK activation
|
Salamone, F. |
|
2012 |
44 |
S1 |
p. S2- 1 p. |
artikel |
89 |
OC-23 Urinary ethyl glucuronide improves the detection of alcohol consumption in liver transplant candidates and recipients
|
Piano, S. |
|
2012 |
44 |
S1 |
p. S8- 1 p. |
artikel |
90 |
OC-15 Videocapsule endoscopy in patients with portal hypertension: small bowel findings before and following transgiugular intrahepatic portosystemic shunt
|
Pentassuglio, I. |
|
2012 |
44 |
S1 |
p. S6- 1 p. |
artikel |
91 |
T-40 Alphafetoprotein and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre cohort study
|
Vitale, A. |
|
2012 |
44 |
S1 |
p. S27- 1 p. |
artikel |
92 |
T-2 A morphometric and immunohistochemical study to assess the benefit of an SVR in HCV cirrhotic patients
|
D' Ambrosio, R. |
|
2012 |
44 |
S1 |
p. S14- 1 p. |
artikel |
93 |
T-13 A new panoramic 3-dimensional US (3D NAV CEUS) for HCC detection during follow up in cirrhotic patients
|
Giangregorio, F. |
|
2012 |
44 |
S1 |
p. S18- 1 p. |
artikel |
94 |
T-16 Contrast-enhanced CT scan differentiates hepatocellular carcinoma and intrahepatic cholangiocarcinoma in cirrhosis
|
Iavarone, M. |
|
2012 |
44 |
S1 |
p. S19- 1 p. |
artikel |
95 |
T-25 Drug interaction profile of telaprevir
|
Garg, V. |
|
2012 |
44 |
S1 |
p. S22- 1 p. |
artikel |
96 |
T-43 DXA assessment of bone mineral content during the first year after liver tranplantation
|
Cenni, A. |
|
2012 |
44 |
S1 |
p. S28- 1 p. |
artikel |
97 |
T-11 Early assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusional computed tomography: pilot study
|
Sacco, R. |
|
2012 |
44 |
S1 |
p. S17- 1 p. |
artikel |
98 |
T-34 Effect of statin therapy vs diet in hypercholesterolemic patients affected by nonalcoholic steatohepatitis (NASH)
|
Carnelutti, A. |
|
2012 |
44 |
S1 |
p. S25-S26 2 p. |
artikel |
99 |
T-31 Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C
|
Maggioni, P. |
|
2012 |
44 |
S1 |
p. S24-S25 2 p. |
artikel |
100 |
T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study
|
Andreone, P. |
|
2012 |
44 |
S1 |
p. S23- 1 p. |
artikel |
101 |
T-8 Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: high efficacy and favorable safety profile over 3 years of treatment
|
Lampertico, P. |
|
2012 |
44 |
S1 |
p. S16- 1 p. |
artikel |
102 |
T-45 Fetuin-A is an independent predictor of both NAFLD and coronary artery disease assessed through coronarography
|
Ballestri, S. |
|
2012 |
44 |
S1 |
p. S29- 1 p. |
artikel |
103 |
T-42 Functional role and therapeutic potentials of Sonic hedgehog in an experimental model of biliary obstruction
|
Gaetani, E. |
|
2012 |
44 |
S1 |
p. S28- 1 p. |
artikel |
104 |
T-44 HCC cell carries cytoplasmatic drug-storing vesicles as chemoresistance mechanism
|
Colombo, F. |
|
2012 |
44 |
S1 |
p. S29- 1 p. |
artikel |
105 |
T-5 High sCD36 plasma level is associated with steatosis and its severity in patients with chronic genotype 1 hepatitis C
|
Petta, S. |
|
2012 |
44 |
S1 |
p. S15- 1 p. |
artikel |
106 |
T-6 Hyperuricemia is associated with severe steatosis in patients with chronic hepatitis C
|
Petta, S. |
|
2012 |
44 |
S1 |
p. S15- 1 p. |
artikel |
107 |
T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study
|
Andreone, P. |
|
2012 |
44 |
S1 |
p. S22-S23 2 p. |
artikel |
108 |
T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study
|
Andreone, P. |
|
2012 |
44 |
S1 |
p. S23-S24 2 p. |
artikel |
109 |
T-37 Impaired pancreatic duodenal homeobox protein 1 (PDX-1) expression promotes diabetes and hepatocellular carcinoma (HCC) development in mice
|
De Minicis, S. |
|
2012 |
44 |
S1 |
p. S26- 1 p. |
artikel |
110 |
T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation
|
Milazzo, M. |
|
2012 |
44 |
S1 |
p. S31- 1 p. |
artikel |
111 |
T-1 Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis
|
Sansoè, G. |
|
2012 |
44 |
S1 |
p. S14- 1 p. |
artikel |
112 |
T-52 Interferon-stimulated gene expression and IL28B genotype predict rapid viral response during standard therapy for chronic hepatitis C
|
Burlone, M.E. |
|
2012 |
44 |
S1 |
p. S31- 1 p. |
artikel |
113 |
T-32 In vivo and in vitro models support the therapeutic effects of acycloguanosyl 5’-thymidyltriphosphate for the hepatocellular carcinoma via telomerase activation
|
Tarocchi, M. |
|
2012 |
44 |
S1 |
p. S25- 1 p. |
artikel |
114 |
T-46 Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib?
|
De Santis, A. |
|
2012 |
44 |
S1 |
p. S29- 1 p. |
artikel |
115 |
T-33 Knockdown of Ruvbl-1 reduces HCC cells growth in vitro and in a new orthotopic mice model
|
Mello, T. |
|
2012 |
44 |
S1 |
p. S25- 1 p. |
artikel |
116 |
T-38 Leading role of SerpinB3 in molecular signatures of worse prognosis in hepatocellular carcinoma
|
Turato, C. |
|
2012 |
44 |
S1 |
p. S27- 1 p. |
artikel |
117 |
T-15 Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers
|
Ferrigno, A. |
|
2012 |
44 |
S1 |
p. S18-S19 2 p. |
artikel |
118 |
T-41 Major bleeding episodes among patients with HCC during sorafenib treatment: the dark side of a relatively safe drug?
|
De Santis, A. |
|
2012 |
44 |
S1 |
p. S28- 1 p. |
artikel |
119 |
T-39 Metal metabolism in patients with hepatic encephalopathy
|
Marano, M. |
|
2012 |
44 |
S1 |
p. S27- 1 p. |
artikel |
120 |
T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments
|
Fornari, F. |
|
2012 |
44 |
S1 |
p. S17- 1 p. |
artikel |
121 |
T-48 NAFLD fibrosis score is associated with cardiovascular disease in patients undergoing coronarography
|
Gentilucci, U. Vespasiani |
|
2012 |
44 |
S1 |
p. S30- 1 p. |
artikel |
122 |
T-51 NAFLD to NASH: an experimental study on the early events of fibrosis
|
Barbero-Becerra, V.J. |
|
2012 |
44 |
S1 |
p. S31- 1 p. |
artikel |
123 |
T-18 Natural history of primary biliary cirrhosis: experience from a single center in southern Italy
|
Licata, A. |
|
2012 |
44 |
S1 |
p. S19-S20 2 p. |
artikel |
124 |
T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study
|
Andreone, P. |
|
2012 |
44 |
S1 |
p. S24- 1 p. |
artikel |
125 |
T-30 Preservation of obese rat livers by subnormothermic machine perfusion protects dipeptidylpeptidase–IV activity and expression in the biliary tree
|
Tarantola, E. |
|
2012 |
44 |
S1 |
p. S24- 1 p. |
artikel |
126 |
T-3 Ramp-up strategy and long-term results of sorafenib in advanced-stage hepatocellular carcinoma under daily clinical practice conditions
|
Sacco, R. |
|
2012 |
44 |
S1 |
p. S14- 1 p. |
artikel |
127 |
T-49 Retreatment with pegylated interferon and ribavirin of HIV-HCV-coinfected patients: a comparative meta-analysis report
|
Basso, M. |
|
2012 |
44 |
S1 |
p. S30- 1 p. |
artikel |
128 |
T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219)
|
Picchio, G. |
|
2012 |
44 |
S1 |
p. S22- 1 p. |
artikel |
129 |
T-12 Rods and rings autoantibodies developing in chronic hepatitis C patients treated with peginterferon and ribavirin target inosine-5’-monophosphate dehydrogenase 2 (IMPDH2)
|
Covini, G. |
|
2012 |
44 |
S1 |
p. S17-S18 2 p. |
artikel |
130 |
T-36 Role of bacterial translocation in liver fibrosis and HCC development
|
De Minicis, S. |
|
2012 |
44 |
S1 |
p. S26- 1 p. |
artikel |
131 |
T-35 SerpinB3 downregulates the proapoptotic p66Shc protein in human hepatoma cells
|
Ruvoletto, M. |
|
2012 |
44 |
S1 |
p. S26- 1 p. |
artikel |
132 |
T-21 Single-step balloon-occluded percutaneous radio-frequency thermal ablation (RFA) plus transcatheter arterial chemoembolization (TACE) for treatment of “complex” unresectable hepatocellular carcinoma
|
Iezzi, R. |
|
2012 |
44 |
S1 |
p. S20-S21 2 p. |
artikel |
133 |
T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis
|
Borghi, A. |
|
2012 |
44 |
S1 |
p. S21-S22 2 p. |
artikel |
134 |
T-17 Sustained virologic response to interferon prevents the lethal consequence of clinical decompensation in patients who develop a hepatocellular carcinoma post antiviral-treatment
|
Bruno, S. |
|
2012 |
44 |
S1 |
p. S19- 1 p. |
artikel |
135 |
T-7 The course of bone mineral density in patients with chronic hepatitis B long term treated with nucleos(t)ide analogs: a longitudinal cohort study
|
Viganò, M. |
|
2012 |
44 |
S1 |
p. S15-S16 2 p. |
artikel |
136 |
T-22 The effect of liver transplant on fatigue in patients with primary biliary cirrhosis
|
Carbone, M. |
|
2012 |
44 |
S1 |
p. S21- 1 p. |
artikel |
137 |
T-47 Thrombocytopenia and neutropenia during peginterferon plus ribavirin combination therapy in cirrhotic patients with HCV infection
|
Iacobellis, A. |
|
2012 |
44 |
S1 |
p. S30- 1 p. |
artikel |
138 |
T-4 Thyroid-stimulating hormone serum level, liver thyroid-stimulating hormone-receptor, and severe fibrosis in genotype 1 chronic hepatitis C patients with normal thyroid function
|
Petta, S. |
|
2012 |
44 |
S1 |
p. S15- 1 p. |
artikel |
139 |
T-20 Tissue Doppler imaging analysis, a new method for the diagnosis of diastolic dysfunction in cirrhotic cardiomyopathy
|
Barghini, V. |
|
2012 |
44 |
S1 |
p. S20- 1 p. |
artikel |
140 |
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection
|
Coppola, N. |
|
2012 |
44 |
S1 |
p. S18- 1 p. |
artikel |
141 |
T-19 Vitamin D–PTH axis in HCV infection
|
Morisco, F. |
|
2012 |
44 |
S1 |
p. S20- 1 p. |
artikel |
142 |
T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice
|
Lampertico, P. |
|
2012 |
44 |
S1 |
p. S16-S17 2 p. |
artikel |